卖什么
The only R&D data cloud for life sciences
商业模式拆解
买家：谁掌握预算？
Scientific IT, R&D/data leaders and AI leaders at biopharma (pages for AI leader, development, research, scientific IT, quality).
触发点：什么让他们现在购买？
未核实Fragmented instrument and lab data blocking scientific AI; replatforming legacy SDMS.
工作流：什么输入变成什么输出？
Integrate instrument/ELN/LIMS data, engineer it into harmonized AI-ready datasets, automate scientific data workflows, run analytics/AI apps (e.g., Chromatography Insights) on Tetra OS with GxP compliance.
经济账：省了什么，怎么收费？
未核实Enterprise platform subscription plus data-replatforming services; price not published.
渠道：怎么接触到客户？
未核实Enterprise demo/contact-led sales into pharma; outcomes pages and CEO content marketing.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2015 夏季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.